What we do

From 2021 to 2025, the project will: 

1. Develop and apply innovative sampling, sample preparation and analytics to assess internal (human matrices) and external (abiotic) exposure to MNP
2. Develop and apply a human-based in vitro toolbox for testing epithelial transfer and immunotoxicity of MNP
3. Assess exposure and biological effects of MNP in real-life scenarios
4. Establish a risk assessment strategy and execute HRA for MNP
5. Manage data for current use in developing MNP risk assessment strategy and for future in silico predictions
6. Exchange and communicate information and knowledge to our stakeholders